NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, July 9, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

NYSX ETF component Alibaba comes off gains of 11%

Ashley Mastronardi delivers the pre-market update on July 9th

  • Investors are monitoring new developments in the Middle East while also dissecting the latest Fed minutes.
    • As of 8 AM ET, ICE Brent Crude Oil is $78 a barrel.  
  • The Global X NYSE 100 ETF is coming off a winning session, paced by Chinese e-commerce giant Alibaba (NYSE: BABA).
    • Shares rose more than 11% after analysts from UBS highlighted the company’s growth angle.
  • NYSE Live will provide coverage of Brazilian airline Azul’s uplifting to the NYSE, including the executive’s remarks and an interview with CEO John Rodgerson.

Opening Bell
Azul Airlines (NYSE: AZUL) celebrates its uplisting to the NYSE

Closing Bell
Ladenburg Thalmann celebrates its 150th anniversary

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

First Eagle Investments at NYSE on July 8
First Eagle Investments at NYSE on July 8

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Animal charity Humane Society International Australia becomes 'Humane World for Animals' to better encompass mission and global presence

SYDNEY, Feb. 14, 2025 /PRNewswire/ — Animal charity Humane Society International (HSI)…

Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting

CHENGDU, China, April 22, 2026 /PRNewswire/ — The 2026 American Society of…

Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors

MORRISVILLE, NC., July 8, 2024 /PRNewswire/ — Immorna Biotherapeutics, Inc. (Immorna), a…